CMC is located in Taizhou
- Central part of Jiangsu
- Yangtze River Delta
- 2100 years history
- Total area of 5793 km2
- 5.07 million population
Transportation Network
Milestone
- Feb. 2005 Strategic decision
- Nov. 2006 Infrastructure construction
- Mar. 2009 National-level park
- Feb. 2010 Support from ministries
- Aug. 2011 Jiangsu CFDA CMC branch
- Dec. 2013 AstraZeneca acquires GMP license
- Dec. 2014 Roche-Chugai opening ceremony
- Aug. 2015 Medical Device Clustering Zone established
Fast Clustering
- About 700 Medical-related Companies
- 182- pharmaceutical R&D / manufacturing
- 22- pharmaceutical sales and distribution
- 255- medical device manufacturing
- 180- medical device sales and distribution
- 10- vaccine manufacturing
- 15- health food and nutrition / cosmetic
- 50- other
CMC Advantage
Jointly Constructed by Ministries
Partners and Fund
Regulation Support
Jiangsu Institute for Food and Drug Control CMC Branch .
Jiangsu Provincial Medical Instrument Testing Institute CMC Branch
Diagnostic Reagent Testing Center
Regulation Support
patent application
IP protection and legal aid
Subsidies for patent invention application fee
Talent Support
Talent program
- The Recruitment Program of Global Experts-Thousand Talents Program
- Hundred Talent Program for Oversea Expert
- Innovative and Entrepreneurial Talent Program
- “113” Talent Program
Talent recruitment
- Special job fair for companies
- CMC head-hunting company
- Employment alliance of universities in Jiangsu
CMC Incentives Summary
- 1: Decorated Lab and GMP Standard Workshop for lease (Rent discount or Rent free period)
- 2: Reward for product varieties (Drug, Vaccine, Bio-technology, Medical Device, TCM)
- 3: Assistance in application for Science and Technology Projects (National, Provincial, Municipal)
- 4: Reward for talent and team (Entrepreneurial or Innovative)
- 5: Tax Incentive (Corporate and Personal)
CMC Achievements
Beyond Laboratory Ltd (Beyond Lab), was established in 2014 and aims to build a bridge between companies in the UK and Chinese investors. Different to other investment agents, Beyond Lab is a UK company created by scientists for scientists. We focus on the medical/health related sectors including Life Sciences, Medical technology and devices, Healthcare and Pharmaceuticals. Our expertise includes Cancer Research, Diabetes, Neurosciences and Healthcare Software Solutions. We bring the British companies and Chinese investors together and help them to build up a long-term, win-win business partnership.
-
Beyond Lab.
31 Old Burlington Street
Mayfair
London, W1S 3AS - +44 7478 757322
-
info@beyondlaboratory.com
www.beyondlaboratory.com -
Disclaimer
Beyondlaboratory Ltd (BL) is unregulated company acting within exemptions set out within the Financial Services and Markets Act (“the Act”) in order to enable parties to communicate and to act as an introducer. CIC facilitates UK businesses seeking funding to present their businesses to Chinese individuals and companies which are looking to fund companies or otherwise cooperate with them in any number of ways. Beyondlaboratory Ltd does not give any assurance that the business presenting in this document is suitable for investment and that funding is appropriate. Accordingly investors should conduct their own due diligence and consult their legal, financial and tax advisers before entering into any contractual obligation with this business.